Yale University

R. Douglas Bruce, M.D., M.A., M.Sc.

Roles:
  • Chief of Medicine, Cornell Scott-Hill Health Center
  • Associate Clinical Professor of Medicine, Yale School of Medicine
  • Investigator, Clinical and Health Services Research Core, CIRA
Contact:

Biography:

Clinical Interests
Dr. Bruce's interests reside at the intersection of substance abuse/dependence and infectious diseases, particularly HIV and Hepatitis C. Dr. Bruce is Chief of Medicine of the Cornell Scott-Hill Health Center, a large community health center in New Haven, CT, whose goal is to improve the healthcare of the 35,000+ people that the Center cares for in 19 clinical sites through the community. Dr. Bruce has worked clinically in the treatment of HIV and Hepatitis C in drug treatment settings, jail/prison, and in mobile healthcare settings, and has assisted in the development and implementation of buprenorphine in each of these clinical environments. Over the last several years, he has trained medical providers on evidence-based treatments for addiction and HIV. Dr. Bruce has trained clinical providers from Armenia, Azerbaijan, China, Georgia, Indonesia, Kazakhstan, Kyrgyzstan, Lithuania, Malaysia, Moldova, Poland, Tajikistan, The Russia Federation, and Ukraine.


Research Interests
Dr. Bruce's scholarly work focuses on the intersection of substance abuse/dependence and infectious diseases, particularly HIV and Hepatitis C. He was the recipient of a NIDA Career Development Award to improve health outcomes among drug users at the intersection of infectious diseases (especially HIV and HCV) and addiction. There are several specific sub-themes that are embedded in that overall focus and they are: 1) integration efforts to improve health outcomes; 2) pharmacokinetic interaction studies between HIV/HCV/TB treatments and treatments for substance dependence (e.g., buprenorphine/methadone); 3) ethical issues regarding the conduct of research and the provision of clinical care at the intersection of infectious diseases and addiction.